Table 6– Sleep and respiratory data in sleep apnoeic females at baseline and after continuous positive airway pressure (CPAP) and CPAP treatment phases
BaselinePost-CPAPPost-sham-CPAP
Sleep latency min21.15±2.5516.95±2.9618.34±3.71
WASO min90.45±11.9861.08±8.82*79.82±14.16
TWT min111.61±12.4578.03±9.76*98.16±14.85
Sleep time TST %76.83±2.5783.62±2.05*79.62±3.08
N1 %13.96±1.2510.10±0.87*15.09±1.76#
N2 %54.74±2.4057.52±2.5057.23±2.61
SWS %18.63±2.1317.59±2.4216.81±2.19
REM %12.95±6.4812.92±5.8510.87±5.25
REM latency min139.57±15.75141.04±18.11167.01±15.82
AHI32.09±3.952.15±0.62*31.82±6.07#
Minimum Sa,O283.05±0.8992.05±0.55*83.05±1.13#
  • Data are presented as mean±se. WASO: wake time after sleep onset; TWT: total wake time; TST: total sleep time; N1: stage 1 nonrapid eye movement (NREM) sleep; N2: stage 2 NREM sleep; SWS: slow wave sleep; REM: rapid eye movement; AHI: apnoea/hypopnoea index; Sa,O2: arterial oxygen stauration. *: p<0.05 between baseline and post-CPAP treatment; #: p<0.05 between CPAP and sham-CPAP.